Actively Recruiting
Early Life Thiamine Supplementation to Improve Infant Brain Development in Cambodia A Randomized Study Comparing Standard and Higher Dose Multiple Micronutrient Supplements
Led by Mount Saint Vincent University · Updated on 2026-08-31
1972
Participants Needed
1
Research Sites
12 weeks
Total Duration
AI-Summary
What This Trial Is About
Thiamine, also known as vitamin B1, is crucial for energy metabolism, brain development, and overall health. This study focuses on pregnant women in Cambodia, where white rice is a staple food low in thiamine, raising concerns about deficiency in mothers and their infants. Researchers are evaluating whether higher thiamine supplementation during pregnancy and early childhood improves infant brain development compared to the standard recommended dose. Participants will receive either a standard multiple micronutrient supplement containing the recommended daily intake of thiamine or a higher dose supplement. Pregnant women will take tablets starting from 12 to 16 weeks of pregnancy through six months postnatal, after which infants will receive liquid supplement drops daily until 18 months old. Both supplements contain the same micronutrients except for differing thiamine levels. During the study, participants will be monitored from pregnancy through to when their child is 18 months old. Researchers will assess infant neurocognitive development using the Mullen Scales of Early Learning at 18 months. The study also includes adjustments for health center, gestational age at enrollment, and birth measurements. The overall participation lasts from early pregnancy until the child reaches 18 months of age.
CONDITIONS
Brief Title
Early Life Thiamine Study
Research Team
K
Kyly C Whitfield
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here